Anestis Moumtzouoglou

Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes

Nikolaos P. E. Kadoglou, Nikolaos Sailer, Anestis Moumtzouoglou et al. · Experimental and Clinical Endocrinology & Diabetes · 2009 · 94 citations

Intensive Lipid-lowering Therapy Ameliorates Novel Calcification Markers and GSM Score in Patients with Carotid Stenosis

Nikolaos P. E. Kadoglou, Thomas Gerasimidis, Anestis Moumtzouoglou et al. · European Journal of Vascular and Endovascular Surgery · 2008 · 84 citations

Metabolic Syndrome, Lipid Disorder, Vascular Disease +12

Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization

Nikolaos P. E. Kadoglou, Nikolaos Sailer, Anestis Moumtzouoglou et al. · Journal of Vascular Surgery · 2009 · 81 citations · Full text

Moderate Lipid-lowering Treatment, Lipid Disorder, Vascular Disease +9

Transient contrast encephalopathy after carotid angiography mimicking diffuse subarachnoid haemorrhage

Stamatia Potsi, Danai Chourmouzi, Anestis Moumtzouoglou et al. · Neurological Sciences · 2011 · 59 citations

Vascular Image, Medicine, Intracranial Pressure +10

Adipokines: a novel link between adiposity and carotid plaque vulnerability

Nikolaos P. E. Kadoglou, Nikolaos Sailer, Anestis Moumtzouoglou et al. · European Journal of Clinical Investigation · 2012 · 40 citations